Filing Details

Accession Number:
0001179110-19-008350
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-02 16:01:24
Reporting Period:
2019-06-28
Accepted Time:
2019-07-02 16:01:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1322295 A Peter Mcclennen C/O Teladoc Health, Inc.
2 Manhattanville Road, Suite 203
Purchase NY 10577
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-28 6,657 $32.50 16,327 No 4 M Direct
Common Stock Acquisiton 2019-06-28 10,059 $38.55 26,386 No 4 M Direct
Common Stock Disposition 2019-06-28 16,716 $65.00 9,670 No 4 S Direct
Common Stock Acquisiton 2019-07-01 2,208 $38.55 11,878 No 4 M Direct
Common Stock Disposition 2019-07-01 2,208 $67.85 9,670 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2019-06-28 6,657 $0.00 6,657 $32.50
Common Stock Employee Stock Option (right to buy) Disposition 2019-06-28 10,059 $0.00 10,059 $38.55
Common Stock Employee Stock Option (right to buy) Disposition 2019-07-01 2,208 $0.00 2,208 $38.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
136,619 2027-11-03 No 4 M Direct
72,851 2028-03-01 No 4 M Direct
70,643 2028-03-01 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019.
  2. Represents the weighted average price of transactions ranging from $67.52 to $68.06. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The option vests as to 25% of the shares on November 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
  4. The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.